wei sun

Dr. wei sun


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2019 in BioMed Research International
Verified
Journal Article
Open access
JMJinhui Ma
Jinhui Ma
JGJuncheng Ge
Juncheng Ge
FGFuqiang Gao
Fuqiang Gao
BWBailiang Wang
Bailiang Wang
DYDebo Yue
Debo Yue
WWWeiguo Wang
Weiguo Wang
The immunologic factors have been implicated in the pathogenesis of osteonecrosis. We aimed to investigate the potential role of immune regulatory cells in the development of osteonecrosis of femoral head (ONFH). Sixty-seven patients diagnosed with ONFH and fifty-eight age-, height-, and weight-matched healthy subjects were included in this retrospective study between September 2015 and September 2018. The flow cytometry was used to test the count, percentage, and ratio of T and B lymphocyte subsets in peripheral blood. The T and B lymphocyte levels were compared among different ARCO stages, CJFH types, and etiology groups. The total lymphocyte count, CD3+T cells, Ts cells (CD3+CD8+), B-1 cell count, and B-1 cells (CD5+CD19+) were significantly higher in the patients with ONFH than those in the control subjects. The percentage of T lymphocytes in the patients with ARCO IV stage was significantly smaller than that in the ONFH patients with ARCO II and III stages. The percentage of inhibitory T lymphocytes in patients with CJFH type L3 was significantly smaller than that in the patients with types L1 and L2. In terms of the different ONFH etiologies, the total lymphocyte count and Ts cells (CD3+CD8+) were significantly lower in the ONFH patients induced by excessive alcohol intake than those in the idiopathic ONFH patients. Our results seem to indicate that immune regulatory cells, such as T and B lymphocytes, play an important role in the pathogenesis of ONFH. The development and progression of ONFH may be associated with immune system imbalance.

24 December 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XWXinjie Wu
Xinjie Wu
WSwei sun
wei sun
MTmingsheng tan
mingsheng tan
Steroid-induced osteonecrosis of the femoral head (ONFH) is a severe orthopedic disease caused by the long-term administration of glucocorticoids. The main pathological feature of ONFH is the gradually progressive necrosis of bone cells and the bone marrow, ultimately resulting in structural changes or even complete collapse of the femoral head. However, the exact pathogenic mechanism of ONFH remains unknown. Noncoding RNAs (ncRNAs) have emerged as very powerful regulators of gene expression, functioning at both transcriptional and posttranscriptional levels in the pathogenesis of ONFH. Here, we review the current knowledge of the role of ncRNAs, including microRNAs, long noncoding RNAs, and circular RNAs, in the pathogenesis of steroid-induced ONFH. Further focus and validation of these associations can provide new insight into the pathogenic mechanisms at the molecular level to suggest targets for treatment and prevention.

26 November 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XWXinjie Wu
Xinjie Wu
WSwei sun
wei sun
MTMingsheng Tan
Mingsheng Tan
Background. The present study aims to investigate the incidence and risk factors associated with postoperative delirium in patients undergoing spine surgery. Methods. PubMed, EMBASE, Cochrane Library, and Science Citation Index were searched up to August 2019 for studies examining postoperative delirium following spine surgery. Incidence and risk factors associated with delirium were extracted. Odds ratios (OR) and 95% confidence intervals (CI) were calculated for outcomes. The Newcastle–Ottawa Scale (NOS) was used for the study quality evaluation. Results. The final analysis includes a total of 40 studies. The pooled analysis reveals that incidence of delirium is 8%, and there are significant differences for developing delirium in age (OR 1.07; 95% CI 1.04–1.09), age more than 65 (OR 4.77; 95% CI 4.37–5.16), age more than 70 (OR 15.87; 95% CI 6.03–41.73), and age more than 80 (OR 1.91; 95% CI 1.78–2.03) years, male (OR 0.81; 95% CI 0.76–0.86), a history of alcohol abuse (OR 2.11; 95% CI 1.67–2.56), anxiety (OR 1.74; 95% CI 1.04–2.44), congestive heart failure (OR 1.4; 95% CI 1.21–1.6), depression (OR 2.5; 95% CI 1.52–3.49), hypertension (OR 1.12; 95% CI 1.04–1.2), kidney disease (OR 1.41; 95% CI 1.16–1.66), neurological disorder (OR 4.66; 95% CI 4.22–5.11), opioid use (OR 1.86; 95% CI 1.18–2.54), psychoses (OR 2.77; 95% CI 2.29–3.25), pulmonary disease (OR 1.81; 95% CI 1.27–2.35), higher mini-mental state examination (OR 0.7; 95% CI 0.5–0.89), preoperative pain (OR 1.88; 95% CI 1.11–2.64), and postoperative urinary tract infection (OR 5.68; 95% CI 2.41–13.39). Conclusions. A comprehensive understanding of incidence and risk factors of delirium can improve prevention, diagnosis, and management. Risk of postoperative delirium can be reduced based upon identifiable risk factors.

28 November 2013 in Journal of International Medical Research
Verified
Journal Article
Open access
CYChangqing Ye
Changqing Ye
HJHaiqiang Jin
Haiqiang Jin
RZRui Zhang
Rui Zhang
YSYongan Sun
Yongan Sun
ZWZhaoxia Wang
Zhaoxia Wang
YHYining Huang
Yining Huang
Objective: To investigate the prevalence and implication of cytochrome P450, family 2, subfamily C, polypeptide 9 ( CYP2C9 ) variants and vitamin K epoxide reductase complex, subunit 1 ( VKORC1 )-1639 G > A polymorphisms in Chinese patients receiving warfarin therapy. Methods: Chinese Han patients requiring oral warfarin therapy were consecutively enrolled. Correlations between CYP2C9 *1, *2, *3, *4, *5 variants and VKORC1 -1639 G > A polymorphisms, fourth-day international normalized ratios (INRs) and warfarin maintenance dose were investigated. Results: Out of 101 patients, there were no significant differences in fourth-day INR or warfarin daily maintenance doses between patients with CYP2C9 *1*1 and CYP2C9 *1*3 genotypes. Patients with the VKORC1 -1639 AA genotype had a higher fourth-day INR (1.87 ± 0.14) than those with the VKORC1 -1639 AG genotype (1.32 ± 0.15). Warfarin maintenance dose for patients with the VKORC1 -1639 AA genotype (2.40 ± 0.70 mg/day) was significantly lower than for patients with the VKORC1 -1639 AG genotype (4.83 ± 0.70 mg/day). Conclusions: Unlike Caucasian populations, VKORC1 -1639 G > A polymorphisms in the Chinese population may be the dominant genetic factors associated with warfarin response variability.

1 August 2021 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
XWXinjie Wu
Xinjie Wu
YWYanlei Wang
Yanlei Wang
WSwei sun
wei sun
MTmingsheng tan
mingsheng tan

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XWXinjie Wu
Xinjie Wu
CGChuanying Geng
Chuanying Geng
WSwei sun
wei sun
MTmingsheng tan
mingsheng tan
Objectives. To investigate the incidence and risk factors for osteonecrosis of femoral head (ONFH) in multiple myeloma (MM) patients undergoing dexamethasone‐based regimens (DBRs). Methods. A retrospective study was conducted in MM patients administered DBRs between December 2012 and April 2015. Demographic, clinical, and laboratory data were extracted to compare between two groups. Incidence of ONFH were calculated and risk factors identified by both univariate and multivariate analysis. Results. The study group comprised 105 patients undergoing DBRs. Seven patients with ONFH after DBRs were classified as the ONFH group, and the other 98 patients without ONFH were included in the non‐ONFH group. Incidence of ONFH was 6.7%. Median age of developing ONFH was 51 years (45–64), and the male to female ratio was 6 : 1. A total of 12 femoral heads were involved, including unilateral in 2 patients and bilateral in 5 patients. After the multivariate analysis, four risk factors were confirmed including male, younger age, cumulative dose of dexamethasone, and hyperlipidemia. Conclusion. The overall incidence of ONFH in MM patients treated with DBRs is 6.7%, and 4 risk factors are confirmed including male, younger age, cumulative dose of dexamethasone, and hyperlipidemia in our study.